Evidence map›Paper›PMID 19502556›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2009

sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.

Emmanuel S Buys, Anje Cauwels, Michael J Raher, Jonathan J Passeri, Ion Hobai, Sharon M Cawley, Kristen M Rauwerdink, Helene Thibault, Patrick Y Sips, Robrecht Thoonen and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Genetic modification of hypertension by sGCα1.Trends in cardiovascular medicine · 2013
    Review
  15. Article
  16. Soluble guanylate cyclase modulates alveolarization in the newborn lung.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  17. Article
  18. Review
  19. Assessing murine resistance artery function using pressure myography.Journal of visualized experiments : JoVE · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Emmanuel S BuysDepartment of Anesthesia and Critical Care, Cardiology Division, Anesthesia Center for Critical Care Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. ebuys@partners.org
Anje Cauwels
Michael J Raher
Jonathan J Passeri
Ion Hobai
Sharon M Cawley
Kristen M Rauwerdink
Helene Thibault
Patrick Y Sips
Robrecht Thoonen
Marielle Scherrer-Crosbie
Fumito Ichinose
Peter Brouckaert
Kenneth D Bloch
Massachusetts General Hospital · USHarvard University · USVlaams Instituut voor Biotechnologie · BEMass General Brigham · US

Funding

INHALED NITRIC OXIDER01HL042397 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ZAPOL, WARREN MYRON · 1990 to 2007
$2.8M
Nitric oxide synthase 3 and left ventricular remodelingR01HL070896 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BLOCH, KENNETH D · 2003 to 2006
$1.7M
Impact of nitric oxide synthase on myocardial dysfunction of sepsisR01GM079360 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO · 2007 to 2011
$1.6M
Nitric Oxide/cGMP/Endotoxin-Induced Myocardial DysfunctK08HL071987 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO · 2004 to 2008
$653k
NHLBI NIH HHS HL-42397NHLBI NIH HHS HL-70896NHLBI NIH HHS HL-71987NIGMS NIH HHS R01 GM079360
6 · The paper itself

Abstract

Altered cGMP signaling has been implicated in myocardial depression, morbidity, and mortality associated with sepsis. Previous studies, using inhibitors of soluble guanylate cyclase (sGC), suggested that cGMP generated by sGC contributed to the cardiac dysfunction and mortality associated with sepsis. We used sGC(alpha)(1)-deficient (sGC(alpha)(1)(-/-)) mice to unequivocally determine the role of sGC(alpha)(1)beta(1) in the development of cardiac dysfunction and death associated with two models of inflammatory shock: endotoxin- and TNF-induced shock. At baseline, echocardiographic assessment and invasive hemodynamic measurements of left ventricular (LV) dimensions and function did not differ between wild-type (WT) mice and sGC(alpha)(1)(-/-) mice on the C57BL/6 background (sGC(alpha)(1)(-/-B6) mice). At 14 h after endotoxin challenge, cardiac dysfunction was more pronounced in sGC(alpha)(1)(-/-B6) than WT mice, as assessed using echocardiographic and hemodynamic indexes of LV function. Similarly, Ca(2+) handling and cell shortening were impaired to a greater extent in cardiomyocytes isolated from sGC(alpha)(1)(-/-B6) than WT mice after endotoxin challenge. Importantly, morbidity and mortality associated with inflammatory shock induced by endotoxin or TNF were increased in sGC(alpha)(1)(-/-B6) compared with WT mice. Together, these findings suggest that cGMP generated by sGC(alpha)(1)beta(1) protects against cardiac dysfunction and mortality in murine inflammatory shock models.

Indexed as

Shock, CardiogenicVentricular Dysfunction, LeftAnimalsBlood PressureCalciumCells, CulturedDisease Models, AnimalEchocardiographyEndotoxinsEnzyme ActivationGene Expression Regulation, EnzymologicGuanylate CyclaseKaplan-Meier EstimateMiceMice, Inbred C57BLMice, Mutant StrainsCalciumEndotoxinsGuanylate CyclaseNitric OxideReceptors, Cytoplasmic and NuclearSoluble Guanylyl CyclaseTumor Necrosis Factor-alpha

Identifiers

PMID19502556
PMCPMC2724210
OpenAlexW2025581283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.